The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCTEA.L Regulatory News (CTEA)

  • There is currently no data for CTEA

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Changes

24 Apr 2020 07:00

RNS Number : 7210K
Catenae Innovation PLC
24 April 2020
 

24 April 2020

Catenae Innovation PLC

("Catenae", or the "Company")

 

Directorate Changes

 

Catenae Innovation PLC (AIM: CTEA), the AIM quoted provider of digital media and technology, is pleased to announce the appointment of Brian Thompson and John Farthing to the Board as Non-Executive Chairman and Chief Financial Officer, respectively, with immediate effect.

 

Kevin Everett, Interim Non-Executive Chairman since 17 July 2019 and Non-Executive Director since 16 May 2013, will step down from his role with immediate effect, to pursue other business interests.

 

Brian Thompson's proposed appointment was announced on 31 January 2020. Mr Thompson is an entrepreneur and is the founder owner of Newcastle-based B.T.I.C. Ltd, a successful business that has operated in the insurance industry since 1985. He is also a director of Third Eye Neurotech Ltd.

 

John Farthing's appointment as Chief Financial Officer of the Company was announced on 24 January 2019 and his proposed appointment to the Board was announced on 23 December 2019. John qualified as a Chartered Accountant in 1988. Following a career in stockbroking, John has experience working with both UK listed as well as private companies. John is also a Chartered Fellow of the Chartered Institute for Securities & Investment and a Liveryman of the Worshipful Company of World Traders.

 

Further disclosure on Brian Thompson and John Farthing pursuant to Schedule Two, paragraph (g) (i)-(viii) of the AIM Rules for Companies is set out below.

 

In order to conserve the Company's working capital, the directors have agreed to take part of their remuneration in shares.

 

Guy Meyer, Interim Chief Executive Officer, commented: "I am delighted to welcome both Brian and John to the Catenae Board at this important time in our development. Their wealth of experience, expertise and business network will add considerable value as we take advantage of potential growth opportunities that are presenting themselves."

 

"I would also like to thank Kevin for his contribution to the Company and I wish him all the very best for the future."

 

"We look forward to updating the market on future progress in due course."

 

 

 

Pursuant to Rule 17 and Schedule 2(g) of the AIM Rules for Companies, the following information is disclosed in respect of Brian William Thompson (aged 64) and John Farthing (aged 57):

 

In the 5 years preceding the date of this announcement, Brian Thompson held the following directorships and no partnerships:

 

Current directorships

Past directorships

B.T.I.C. Limited

B.T.I.C (Morpeth) Limited

Little Tinker Limited

Third Eye Technologies Limited

Listenear Limited

Lyncroft Finance Limited

Orbi-Tel Limited

Third Eye Neurotech Limited

 

Mr Thompson holds 31,318,797 ordinary shares in the Company, representing 29.2% of the Company's issued share capital and no options over ordinary shares in the Company.

 

In the 5 years preceding the date of this announcement, John Farthing held the following directorships and partnerships:

 

Current directorships / partnerships

Past directorships / partnerships

Cloisters Capital LLP

Beaufort Securities Limited*

Trust in Media Limited

Charchem Limited

Granville West Limited

Harper, Deane and Farthing Limited

Intoware Limited

Kingston Smith Pension Trustees LLP

Kiru Brand Limited

Niku Restaurant Company Limited

Niku Trading Limited**

Signitoff Limited

SXN21 Limited

 

*Beaufort Securities Limited, a company of which Mr Farthing was a director of until 2 March 2018, entered administration on 1 March 2018 and ended administration on 3 March 2020. There was only one insolvency case.

 

**Niku Trading Limited, a company of which Mr Farthing was a director of until 7 October 2016, entered liquidation within one month of Mr Farthing's tenure as director via a voluntary creditors liquidation. A liquidator was appointed on 18 October 2016 and the company was dissolved on 17 September 2019. There was only one insolvency case.

 

Crowd Source Solutions Limited, a company of which Mr Farthing was a director of, was dissolved via a members voluntary liquidation. A liquidator was appointed on 19 August 2013 and the company was dissolved on 28 October 2014 via a solvent liquidation.

 

Mr Farthing holds 1,341,702 ordinary shares in the Company, representing 1.25% of the Company's issued share capital and no options over ordinary shares in the Company.

 

 

There is no further information to be disclosed in relation to the appointments of Brian Thompson and John Farthing pursuant to AIM Rule 17 and Schedule 2 (g) of the AIM Rules for Companies.

 

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014. The person who arranged for release of this announcement on behalf of the Company was Guy Meyer, Interim Chief Executive Officer of the Company.

 

 

- Ends -

 

For further information please contact:

 

Catenae Innovation PLC

+44 (0) 191 580 8545

Guy Meyer, Interim Chief Executive Officer

Cairn Financial Advisers LLP (Nominated Adviser)

+44 (0)20 7213 0880

Liam Murray

Jo Turner

Brandon Hill Capital Limited Broker

Andy Gutmann

+44 (0) 20 3463 5000

+44 (0)78796 8313

 

Yellow Jersey PR (PR & IR)

+44 (0)20 3004 9512

Sarah Hollins

Annabel Atkins

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOAPPUCWCUPUGRW
Date   Source Headline
9th Feb 20242:44 pmRNSResult of AGM, Change of Name & RPT
17th Jan 20247:00 amRNSFurther re: Convertible Loan & Notice of AGM
4th Dec 20237:00 amRNSFurther re: Hyperneph, Insurance Policy and RPT
29th Sep 20237:00 amRNSHalf-year Report
31st Aug 20231:54 pmRNSRelated Party Transactions
22nd May 20237:00 amRNSFurther re: Hyperneph Software Limited
31st Mar 20232:04 pmRNSRelated Party Transactions
30th Mar 20233:56 pmRNSFinal Results
7th Mar 20237:00 amRNSChange of Accounting Reference Date
21st Feb 20232:11 pmRNSTrading Update
30th Sep 20227:30 amRNSRestoration - Catenae Innovation Plc
30th Sep 20227:00 amRNSHalf-year Report and Convertible Loan
30th Sep 20227:00 amRNSFinal Results
2nd Sep 202212:09 pmRNSCompany Update
30th Jun 20227:00 amRNSFinancial Information to 31 March 2022 and Update
30th May 20227:00 amRNSUpdate
17th May 20227:00 amRNSFurther re:- Hyperneph Software Limited
12th May 202210:07 amRNSHyperneph Software Limited Update
29th Apr 20227:00 amRNSFurther re:- Suspension of Trading on AIM
1st Apr 20227:30 amRNSSuspension - Catenae Innovation PLC
1st Apr 20227:00 amRNSSuspension of Trading on AIM
23rd Mar 20222:10 pmRNSTemporary Suspension and Update
8th Mar 20222:05 pmRNSSecond Price Monitoring Extn
8th Mar 20222:00 pmRNSPrice Monitoring Extension
1st Feb 20222:17 pmRNSExercise of Warrant
26th Jan 202210:10 amRNSExercise of Warrant
4th Jan 20227:00 amRNSChange of Broker
8th Dec 20214:41 pmRNSSecond Price Monitoring Extn
8th Dec 20214:36 pmRNSPrice Monitoring Extension
23rd Sep 20217:00 amRNSCatenae exhibits at UK Construction Week with CHL
15th Sep 20217:00 amRNSIssue of Equity / PDMR / Exercise of Warrants
9th Aug 20217:00 amRNSData Visualisation Order from SaxaVord Space Port
2nd Aug 20212:05 pmRNSSecond Price Monitoring Extn
2nd Aug 20212:00 pmRNSPrice Monitoring Extension
2nd Aug 20217:00 amRNSCollaboration agreement with ProMake Limited
27th Jul 20217:00 amRNSDirector and PDMR remuneration - Conversion
7th Jul 20217:00 amRNSPilot programme with a charity
30th Jun 20212:05 pmRNSSecond Price Monitoring Extn
30th Jun 20212:00 pmRNSPrice Monitoring Extension
30th Jun 20217:00 amRNSHalf Year Results to 31 March 2021
30th Jun 20217:00 amRNSFinal Results
4th May 20217:00 amRNSAcquisition of Hyperneph Software Limited
28th Apr 20216:14 pmRNSHolding(s) in Company
16th Apr 20213:47 pmRNSExercise of Warrant
12th Apr 202111:09 amRNSUpdate re Issue of Warrants
9th Apr 20214:40 pmRNSSecond Price Monitoring Extn
9th Apr 20214:35 pmRNSPrice Monitoring Extension
9th Apr 202111:05 amRNSSecond Price Monitoring Extn
9th Apr 202111:00 amRNSPrice Monitoring Extension
31st Mar 20212:00 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.